Disruption of mitochondrial quality control in peripheral arterydisease: new therapeutic opportunities (2017)
- Authors:
- Autor USP: FERREIRA, JULIO CESAR BATISTA - ICB
- Unidade: ICB
- DOI: 10.1016/j.phrs.2016.11.016
- Assunto: ANATOMIA
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Pharmacological Research
- ISSN: 1096-1186
- Volume/Número/Paginação/Ano: v. 115, p. 96-106, 2017
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
-
ABNT
UETA, Cintia B. et al. Disruption of mitochondrial quality control in peripheral arterydisease: new therapeutic opportunities. Pharmacological Research, v. 115, p. 96-106, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.phrs.2016.11.016. Acesso em: 24 abr. 2024. -
APA
Ueta, C. B., Gomes, K. S., Ribeiro, M. A., Mochly-Rosen, D., & Ferreira, J. C. B. (2017). Disruption of mitochondrial quality control in peripheral arterydisease: new therapeutic opportunities. Pharmacological Research, 115, 96-106. doi:10.1016/j.phrs.2016.11.016 -
NLM
Ueta CB, Gomes KS, Ribeiro MA, Mochly-Rosen D, Ferreira JCB. Disruption of mitochondrial quality control in peripheral arterydisease: new therapeutic opportunities [Internet]. Pharmacological Research. 2017 ; 115 96-106.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1016/j.phrs.2016.11.016 -
Vancouver
Ueta CB, Gomes KS, Ribeiro MA, Mochly-Rosen D, Ferreira JCB. Disruption of mitochondrial quality control in peripheral arterydisease: new therapeutic opportunities [Internet]. Pharmacological Research. 2017 ; 115 96-106.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1016/j.phrs.2016.11.016 - In vivo measurement of aldehyde dehydrogenase-2 activity in rat liver ethanol model using dynamic MRSI of hyperpolarized [1-13C]pyruvate
- Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) Phosphorylation by Protein Kinase Cδ (PKCδ) inhibits mitochondria elimination by lysosomal-like structures following ischemia and reoxygenation-induced injury
- Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) protein-protein interaction inhibitor reveals a non-catalytic role for GAPDH oligomerization in cell death
- Mitochondrial dysfunction in degenerative diseases
- Participação da isoforma proteína quinase C 'beta' II na insuficiência cardíaca
- Nitroglycerin use in myocardial infarction patients
- New therapeutics to modulate mitochondrial dynamics and mitophagy in cardiac diseases
- Mitochondrial quality control in cardiac diseases
- Targeting mitochondrial dysfunction and oxidative stress in heart failure: challenges and opportunities
- Alcohol consumption and vascular disease: other points to consider
Informações sobre o DOI: 10.1016/j.phrs.2016.11.016 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
